Salvus Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Sell |
1,112
-28
| -2% | -$11.4K | 0.26% | 88 |
|
|
2025
Q1 | $567K | Buy |
1,140
+40
| +4% | +$19.9K | 0.36% | 73 |
|
|
2024
Q4 | $572K | Sell |
1,100
-32
| -3% | -$16.6K | 0.37% | 71 |
|
|
2024
Q3 | $700K | Buy |
1,132
+38
| +3% | +$23.5K | 0.43% | 64 |
|
|
2024
Q2 | $605K | Buy |
1,094
+88
| +9% | +$48.7K | 0.42% | 65 |
|
|
2024
Q1 | $585K | Buy |
1,006
+397
| +65% | +$231K | 0.4% | 69 |
|
|
2023
Q4 | $323K | Buy |
609
+4
| +0.7% | +$2.12K | 0.23% | 89 |
|
|
2023
Q3 | $306K | Buy |
605
+59
| +11% | +$29.9K | 0.24% | 90 |
|
|
2023
Q2 | $285K | Sell |
546
-54
| -9% | -$28.2K | 0.22% | 91 |
|
|
2023
Q1 | $346K | Buy |
600
+40
| +7% | +$23.1K | 0.28% | 88 |
|
|
2022
Q4 | $308K | Buy |
+560
| New | +$308K | 0.28% | 79 |
|